Miles Davenport leads the Infection Analytics Program at the Kirby Institute at UNSW Sydney. His team of applied mathematicians and evidence specialists combine pre-clinical and clinical data to understand vaccination and immunity. His team’s work on correlates of protection for SARS-CoV-2 and mpox has informed vaccine approval and public health policy internationally. He has a wide variety of clinical and experimental collaborations both within Australia and overseas. He is a past-President of the Australasian Society for Immunology, past Section Editor at Journal of Immunology and past Senior Editor at eLife.